CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study.
Tan K, Lu S, Chen Y, Song X, Wu X, Jin Z, Yuan F, Zhou Y, Li H, Yang T, Zhou Y, Li Z, Chen F, Zhang S, Guo L, Wang W, Zhao Q, Huo Y, Yang X, Liu J, Chen B, Yan H, Li H, Ke Y, Chen K, Shi D.
Tan K, et al. Among authors: chen k, chen b, chen f, chen y.
Tohoku J Exp Med. 2011 Apr;223(4):277-83. doi: 10.1620/tjem.223.277.
Tohoku J Exp Med. 2011.
PMID: 21467783
Free article.